Wednesday, August 3, 2016

Early Press on Theranos' Talk at AACC 2016 (Links)

For eighteen months, I've run a nearly weekly update on Theranos article, steadily listing news items both favorable and critical across the march of time; here.  There are about 450 newspaper and trade journal links.  This blog entry has had about 3000 hits.

Early reaction to CEO Elizabeth Holmes' presentation at the American Association for Clinical Chemistry (AACC) in Philadelphia this week has trended negative, as shown below.  (Links after the break.)

Youtube Archive (90 minutes): AACC, Youtube, here.

August 1, 2016.
Holmes Speaks at AACC Conference.
Forbes, Matthew Herper, Live Blog (archive) here
WSJ, John Carreyou, here.
CNBC, article and video story, here.
Wired, Nick Stockton, here.
One of the most detailed reports is at Dark Daily, here.
Youtube Archive (90 minutes): AACC, Youtube, here.

August 1, 2016
"Theranos' Highly-Anticipated Defense of Its Tech Is Called a Bait-and-Switch."
Fortune.  By Sy Mukherjee.  Here.

"How Theranos Created and Destroyed Investors' Trust."
Fortune.  By Kent Grayson.  Here.

"Theranos Offers First Glimpse of Technologies, Assay Data to Critical Lab Community."
Genomeweb [subscription].  By Turna Ray.  Here.

August 2, 2016
"The Founder of Theranos Tries to Change the Subject."
The New Yorker.  By Sheelah Kolhatkar.  Here.

"How Theranos' Reboot Could Backfire."
Washington Post.  By Carolyn Y. Johnson.  Here.

"Theranos Plunges Ahead Into a Murky Future."
Statnews.  By Damian Garde.  Here.

August 3, 2016
"Theranos CEO Quietly Steps Down from Presidential Entrepreneurship Program."
California Healthline.  [Name, photo removed from website.]  Here.  At Breitbart, here.


For John P.A. Ioannidis' second Theranos article, in JAMA on July 26, 2016, here.  Photo set below, click to enlarge.